As per the report published by Fior Markets, the global sleep apnea devices market is expected to grow from USD 5.2. Billion in 2017 to USD 10.6 Billion by 2025 at a CAGR of 9.60%during the forecast period from 2018-2025. North America has captured the largest market share and generating the highest revenue during the forecast period. NorthAmerica region dominated the market and was valued around USD 3.01 Million in 2017. Large patient pool and presence of established manufacturers. Technological advancements and availability of these devices in the region is further augmenting the growth of the market. Asia pacific is projected to be fastest growing region in the forecast period owing to large undiagnosed patient pool, rising healthcare expenditure and growing focus of manufacturers in the region.

Global Sleep Apnea Devices Market by Type (Therapeutic Devices, Diagnostic Devices), End User, and Region” and Global Forecast 2018-2025.


Major playersoperating in the market are Koninklijke Philips, Resmed, Braebon Medical, Fisher &Paykel Healthcare, Drive Devilbiss Healthcare, Somnomed, Whole You, Compumedics, Löwenstein Medical, Phillips Healthcare, Weinmann Medical Devices GmbH, Itamar Medical Ltd., Novasom, Curative Medical Inc., Invacare Corporationand others.Major players are engaged in developing new technologies to retain their foothold in the global market. For instance,in March 2018, Nihon Kohdencommercially launched its NKHiQTM Wireless Patient Monitoring System.

The typesegment is classified into therapeutic and diagnostic devices.The Diagnostics devices segment accounted for the largest share and was valued around USD 2.75 Billion in 2017. Rising patient awareness and increasing demand for early diagnosis is driving the growth of the segment. Large number of undiagnosed patients is providing lucrative opportunities to manufacturers, this in turn is expected to drive market growth over the forecast period for diagnostic devices segment.End user segment is bifurcated into sleep laboratories & hospitals and home care/individuals. The home care/individuals segment of the market is estimated to grow at the highest CAGR of 11.74% during the forecast period. This can be attributed to the preference for home care in sleep apnea diagnosed patients.


Sleep apnea is most prevalent in the elderly population which increases the risk of other diseases such as high blood pressure, heart disease, strokes, diabetes, systemic hypertension and depression are expected to enhance the growth of the segment. In addition, Growing awareness regardingis also driving the market.Lack of awareness may restrict thegrowth of the market. However, rising use of portable sleep apnea devices and increasing government support for start-up companies are driving the growth of the market in forecast period.

Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team(,who will ensure that you get a report that suits your needs.